Kiniksa Pharmaceuticals (KNSA) Return on Invested Capital (ROIC)

Price: $23.36
Market Cap: $1.70B
Avg Volume: 594.50K
Country: BM
Industry: Biotechnology
Sector: Healthcare
Beta: 0.478
52W Range: $16.56-28.15
Website: Kiniksa Pharmaceuticals

Return on Invested Capital (ROIC) Summary

Kiniksa Pharmaceuticals's ROIC measures how effectively the company uses its invested capital to generate profits:

  • Annual: -11.26%
  • Quarterly: -2.10%
  • TTM: -11.31%

What is ROIC?

Return on Invested Capital (ROIC) measures how effectively a company uses its capital from debt and equity to generate profits. ROIC is a useful metric for comparing the efficiency of capital allocation between different companies or across time periods within the same company. A higher ROIC indicates a more efficient use of capital.

Related Metrics

Other important metrics to assess Kiniksa Pharmaceuticals's profitability include:

  • ROE (Return on Equity) - measures the return generated on shareholders' equity:
    • Annual: -9.85%
    • Quarterly: -2.03%
    • TTM: -9.92%
  • ROA (Return on Assets) - measures the return generated on the company's assets:
    • Annual: -7.44%
    • Quarterly: -1.53%
    • TTM: -7.44%

These metrics provide insights into Kiniksa Pharmaceuticals's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual ROIC

-11.26%

Quarterly ROIC

-2.10%

TTM ROIC

-11.31%

Kiniksa Pharmaceuticals Historical ROIC

33.63%33.63%8.51%8.51%-16.61%-16.61%-41.73%-41.73%-66.85%-66.85%-91.97%-91.97%-117.08%-117.08%-142.20%-142.20%-167.32%-167.32%-192.44%-192.44%-217.56%-217.56%ROIC-11.26%4.58%29.24%-81.15%-50.51%-72.94%-38.63%-217.56%-44.38%201720172018201820192019202020202021202120222022202320232024202420252025

Historical ROE

107.14%107.14%92.70%92.70%78.26%78.26%63.82%63.82%49.38%49.38%34.94%34.94%20.50%20.50%6.06%6.06%-8.39%-8.39%-22.83%-22.83%-37.27%-37.27%ROE-9.85%3.21%-37.27%23.38%31.19%45.46%53.15%72.32%93.16%201720172018201820192019202020202021202120222022202320232024202420252025

Historical ROA

45.87%45.87%27.63%27.63%9.38%9.38%-8.87%-8.87%-27.12%-27.12%-45.36%-45.36%-63.61%-63.61%-81.86%-81.86%-100.10%-100.10%-118.35%-118.35%-136.60%-136.60%ROA-7.44%2.68%39.89%-67.84%-46.18%-63.59%-32.06%-136.60%-42.45%201720172018201820192019202020202021202120222022202320232024202420252025

Kiniksa Pharmaceuticals Historical Profitability Metrics

The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.

Year ROIC ROE ROA
2024 -11.26% -9.85% -7.44%
2023 4.58% 3.21% 2.68%
2022 29.24% -37.27% 39.89%
2021 -81.15% 23.38% -67.84%
2020 -50.51% 31.19% -46.18%
2019 -72.94% 45.46% -63.59%
2018 -38.63% 53.15% -32.06%
2017 -217.56% 72.32% -136.60%
2016 -44.38% 93.16% -42.45%

Related Metrics

Explore detailed financial metrics and analysis for KNSA.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio